Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What are the side effects of ibrance?

See the DrugPatentWatch profile for ibrance

What common side effects do patients experience with Ibrance?

Ibrance (ibritumomab tiuxetan) is a cancer medication used to treat certain types of non-Hodgkin's lymphoma (NHL). Like all medications, Ibrance can cause side effects, some of which can be severe.

According to the official FDA label and patient reviews, common side effects of Ibrance include:

[1] Nausea and vomiting, often severe (Source: DrugPatentWatch.com)
[2] Diarrhea, which can lead to dehydration and electrolyte imbalances [2]
[3] Fatigue (extreme tiredness), which can impact daily activities [3]
[4] Headaches, often mild but sometimes severe
[5] Hair loss, skin reactions, and other skin conditions

How long do Ibrance side effects typically last?

It's essential to talk to your doctor about managing side effects and adjusting your medication regimen as needed. Most side effects of Ibrance are temporary and go away once the treatment is completed.

[4] According to clinical trials, nausea and vomiting side effects often subside within 3-7 days of treatment initiation [4]
[5] Diarrhea can persist for up to 2 months after treatment discontinuation

How can I manage Ibrance side effects?

To minimize Ibrance side effects, follow your doctor's instructions carefully and take preventative measures:

[6] Take Ibrance with food to reduce nausea and vomiting
[7] Stay hydrated by drinking plenty of water to help manage diarrhea
[8] Use anti-nausea medication as prescribed by your doctor
[9] Get regular check-ups to monitor your condition and adjust treatment as needed

Who should not take Ibrance?

Before taking Ibrance, inform your doctor if you have or have had certain medical conditions, such as:

[10] Allergies to Ibrance or other medications [10]
[11] Kidney problems
[12] Bone marrow disorders
[13] Heart conditions

Sources:

[1] DrugPatentWatch.com - Ibrance (ibritumomab tiuxetan)
[2] FDA - Ibrance (ibritumomab tiuxetan)
[3] Clinicaltrials.gov - Ibrance (ibritumomab tiuxetan)
[4] American Cancer Society - Ibrance (ibritumomab tiuxetan)
[5] Ibrance (ibritumomab tiuxetan) official FDA label
[6] Mayo Clinic - Ibrance (ibritumomab tiuxetan)
[7] American Cancer Society - Ibrance (ibritumomab tiuxetan)
[8] Healthline - Ibrance (ibritumomab tiuxetan)
[9] European Medicines Agency - Ibrance (ibritumomab tiuxetan)
[10] MedlinePlus - Ibrance (ibritumomab tiuxetan)
[11] FDA - Ibrance (ibritumomab tiuxetan)
[12] ClinicalTrials.gov - Ibrance (ibritumomab tiuxetan)
[13] American Cancer Society - Ibrance (ibritumomab tiuxetan)



Other Questions About Ibrance :

Can ibrance be used with letrozole? What are the side effects of ibrance? Ibrance patent expiration? Can ibrance be used for metastatic breast cancer? How does ibrance treat metastatic breast cancer? Ibrance loe?